Vesicular monoamine transporter 2 inhibitor market to reach $2.01 billion by 2030 at 9.9% CAGR, driven by increasing prevalence of parkinson’s disease.
Read More
Venlafaxine market to reach $4.31 billion by 2030 at 4.5% CAGR, driven by rising prevalence of mental health disorders and demand for personalized medicine.
Read More
Veletri market to reach $2.07 billion by 2030 at 7.4% CAGR, driven by increasing prevalence of venous diseases and rising healthcare expenditure.
Read More
Vegetarian Capsules Market Analysis: Understanding The Drivers Behind 11.8% CAGR Through 2030 Growth
Vegetarian capsules market to reach $3.09 billion by 2030 at 11.8% CAGR, driven by increasing adoption of vegan lifestyles and plant based supplements.
Read More
Vasopressin market to reach $2.88 billion by 2030 at 12.6% CAGR, driven by growing prevalence of diabetes and expanding geriatric population.
Read More
Vasodilators market to reach $8.86 billion by 2030 at 5.5% CAGR, driven by rising prevalence of cardiovascular diseases and sedentary lifestyles.
Read More
Vascular endothelial growth factor inhibitor market to reach $16.23 billion by 2030 at 7.6% CAGR, driven by growing prevalence of cancer and macular degeneration.
Read More
Vaginitis therapeutics market to reach $7.4 billion by 2030 at 11.0% CAGR, driven by increasing prevalence of sexually transmitted diseases among women.
Read More
Vaccine adjuvants market to reach $3.13 billion by 2030 at 9.5% CAGR, driven by growing funding for vaccine research and development activities globally.
Read More
Ursodeoxycholic acid market to reach $1.6 billion by 2030 at 10.7% CAGR, driven by rising prevalence of liver diseases and increasing aging population worldwide.
Read More